| NCT06717269 | Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets | RECRUITING | PHASE1 | 2024-11-30 | 2025-03-31 | 2025-02-15 |
| NCT06691828 | Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948 | COMPLETED | PHASE1 | 2024-11-01 | 2024-12-05 | 2024-11-28 |
| NCT06593457 | A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2024-08-20 | 2024-11-14 | 2024-10-29 |
| NCT05131022 | A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies | RECRUITING | PHASE1 | 2022-04-13 | 2028-01 | 2027-01 |
| NCT05107739 | A Study of DeTIL-0255 in Adults With Advanced Malignancies | TERMINATED | PHASE1 | 2021-12-22 | 2023-05-09 | 2023-05-09 |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | RECRUITING | PHASE1 | 2021-09-29 | 2028-02-28 | 2026-08-31 |
| NCT04830137 | A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies | RECRUITING | PHASE1 | 2021-05-05 | 2026-12 | 2025-12 |